14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $18.05 $25.44 Wednesday, 1st May 2024 PHVS stock ended at $24.57. This is 0.0813% less than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.64% from a day low at $23.16 to a day high of $25.16.
90 days $18.05 $33.00
52 weeks $7.93 $33.00

Historical Pharvaris B.V. prices

Date Open High Low Close Volume
Jul 17, 2023 $15.97 $16.00 $15.32 $15.35 65 515
Jul 14, 2023 $15.50 $16.07 $15.45 $15.61 39 957
Jul 13, 2023 $15.55 $15.70 $15.32 $15.65 38 452
Jul 12, 2023 $15.73 $15.84 $14.81 $15.50 42 444
Jul 11, 2023 $16.07 $16.40 $15.25 $15.31 21 934
Jul 10, 2023 $15.74 $16.38 $14.54 $16.32 55 970
Jul 07, 2023 $15.34 $16.02 $14.49 $15.41 28 393
Jul 06, 2023 $15.00 $16.13 $14.08 $15.65 33 306
Jul 05, 2023 $14.55 $15.67 $13.65 $15.58 57 039
Jul 03, 2023 $15.45 $16.38 $13.69 $14.84 57 675
Jun 30, 2023 $15.50 $17.00 $15.14 $15.14 55 421
Jun 29, 2023 $14.50 $15.89 $14.50 $15.50 41 239
Jun 28, 2023 $15.32 $16.59 $14.28 $14.37 132 068
Jun 27, 2023 $15.00 $18.15 $14.75 $16.00 722 363
Jun 26, 2023 $12.00 $14.82 $11.90 $14.82 331 060
Jun 23, 2023 $11.28 $11.66 $11.28 $11.60 1 179
Jun 22, 2023 $11.05 $11.86 $10.50 $11.70 35 940
Jun 21, 2023 $11.20 $11.49 $10.85 $11.43 21 764
Jun 20, 2023 $11.20 $11.70 $10.60 $11.65 93 220
Jun 16, 2023 $11.19 $11.62 $11.17 $11.62 62 887
Jun 15, 2023 $10.72 $11.39 $11.05 $11.17 26 974
Jun 14, 2023 $11.30 $11.40 $10.68 $11.20 7 913
Jun 13, 2023 $10.62 $11.40 $10.60 $10.95 40 793
Jun 12, 2023 $11.42 $11.42 $10.56 $10.90 41 632
Jun 09, 2023 $9.00 $11.65 $8.56 $11.33 29 990
Click to get the best stock tips daily for free!

About Pharvaris B.V.

Pharvaris B.V. Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, rapid exposure soft capsule for patients suffering from acute HAE attacks and is under Phase 2 clinical ... PHVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT